Pfizer sponsored. Posts are intended for US healthcare professionals (HCPs) only and may not be suitable outside the US. pfi.sr/qr5
Joined January 2022
- Tweets 1,429
- Following 0
- Followers 7,032
- Likes 0
1,054 Photos and videos
Pinned Tweet
21 Jul 2022
Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. Our community guidelines can be found here: pfi.sr/JJG
7
22
Jun 15
U.S. data show an age-adjusted prevalence of migraine/severe headache around 14–16% in White, Black, and Hispanic groups, with lower prevalence in Asian Americans—yet access barriers and care experiences differ. pfi.sr/raceprimerPMPuuid
#MHAM #NeuroTwitter
39
Jun 13
Heading to #EHA2026? Pfizer Oncology and Rare Hematology will be at the poster presentations sharing the latest findings on #MultipleMyeloma and #SickleCellDisease. Explore the full congress program here: pfi.sr/f9c
125
Jun 12
Practical tip for busy clinics: the 3 item ID MigraineTM tool can support timely recognition. Two or more positive responses are associated with sensitivity of 0.81. Learn more here: pfi.sr/MAHM2026p1
#PrimaryCare #Neurology #MHAM #NeuroTwitter
1
64
Jun 12
We’re bringing our latest research to #EHA2026! Join Pfizer Oncology and Rare Hematology at the poster presentations on #MultipleMyeloma and #hemophilia this Friday. Full details are in the congress program: pfi.sr/f9c
1
103
Jun 11
We invite organizations to apply to the HTRS | Pfizer Visiting Professorship Program supporting shared decision making in hemophilia.
To learn more and submit proposals, visit pfi.sr/htrs3. Deadline for submission: June 18, 2026.
51
Jun 11
June 25th is World Vitiligo Day. Join Pfizer and Dr. Erik Domingues in recognizing #Vitiligo and its impact on patients’ lives. Explore the science shaping our understanding of this condition. Visit Pfizer Medical to learn more. pfi.sr/fD3
#Dermatology
1
113
Jun 8
The FDA has approved an update to our hemophilia treatment indication which follows the October 2024 approval in non-inhibitor patients with hemophilia. Learn more at pfi.sr/pi26
107
Jun 6
Don’t miss out - data from Pfizer’s Phase 2b VESPER clinical trials are being presented today at 8:00 AM.
Meet us at our booth (#631)
#ADASciSessions #GLP1
121
Jun 5
Visit Pfizer Oncology and Rare Hematology at #EHA2026, booth #C4, to see how we’re helping to shape the forefront of #hematology. Explore the full congress program to learn more about our 11 poster presentations: pfi.sr/f9c
101
Jun 4
Attending #ADA2026?
Meet us at our booth (#631) from June 5-8.
Data from Pfizer’s Phase 2 VESPER clinical trials will be presented on Saturday!
#ADAScisessions #GLP1
235
Jun 4
During migraine visits, a few structured data points go a long way. A headache diary can make follow-ups faster and more actionable. Learn more about this and other migraine topics here: pfi.sr/com_t_and_m
#HeadacheMedicine #NeuroTwitter #MHAM
52
Jun 4
Today, we present three of our four late breakers at the AHS Annual Scientific meeting. These are some of the 20 posters and presentations we have this year at AHS. You can also find us at booth #301. Come by to learn more about our active clinical trials. #AHS2026 #neurotwitter
1
54
Jun 3
Hear it from the expert! Watch Dr. Fred Cohen demystify some of the common myths about migraine and discuss its impact on brain, focusing on the importance of recognition, diagnosis & management of #migraine.
More coming soon in the series!
#neurotwitter
pfi.sr/fDb
71
Jun 3
Heading to the American Headache Society Annual Scientific meeting in Orlando?
Come by our medical booth and visit our posters and presentations throughout the conference to learn more about our #migraine research and active clinical trials.
#AHS2026
#neurotwitter
65
Jun 1
Migraine is a common, disabling neurologic disease. This #MHAM, consider a quick diagnostic criteria refresher to support timely recognition of migraine. Learn more about this and other migraine topics here: ratemigraine.com
#Migraine #NeuroTwitter
1
100
Jun 1
We are pleased to announce the publication of a new post‑hoc analysis comparing the impact of a JAKi and a biologic on itch relief and quality of life improvements in patients with moderate‑to‑severe #AtopicDermatitis. #Eczema #Dermatology
pfi.sr/fHM
60
May 27
Menopause is natural, yet many women navigate it without support. Let’s close the gap.
Click here for more: pfi.sr/xx3
#Menopause #WomensHealth
91
May 27
Pfizer is proud to announce the release of a video abstract that summarizes a recent publication about 3-year efficacy and safety data for a treatment for severe #AlopeciaAreata.
#Dermatology
pfi.sr/fuD
72
May 26
We invite organizations to apply to Pfizer’s fellowship grant supporting shared decision making, patient education, and multidisciplinary team-based care in hemophilia.
To learn more and submit proposals, visit pfi.sr/rfpf. Deadline for submission: May 28, 2026.
97
May 22
Pfizer believes in the importance of advancing research in #ATTRCM. We welcome those interested to learn about our research grant opportunity exploring the development of a shared decision-making tool. The last day to apply is June 3th 2026: pfi.sr/fDA
94